How Vivos Therapeutics, a Leading OSA Device Maker, Improved Patient Engagement Through a Mobile-First Strategy With blueBriX
Vivos Therapeutics, a pioneer in non-invasive treatment for obstructive sleep apnea (OSA), was determined to expand its clinical impact beyond traditional care models. When it acquired MyoSync, a company specializing in Orofacial Myofunctional Therapy (OMT), it gained not just a treatment extension—but an opportunity to rethink how therapy could be delivered.
This wasn’t Vivos’s first partnership with blueBriX. Previously, the two teams collaborated to build AireO2, a dental EHR platform designed to simplify provider workflows and centralize patient data across practices. That solution helped Vivos rapidly expand its customer base by improving clinical efficiency and enabling consistent care delivery across its growing network of providers.
Building on the success of AireO2, Vivos and blueBriX set out to solve a new challenge: enabling mobile-first patient engagement tailored to Orofacial therapy needs. The result was the MyoSync App—a unified platform that empowers patients with personalized digital tools while giving clinicians the oversight and structure needed to deliver better outcomes.
blueBriX, integrated with the Aire02 system, offers a comprehensive telemedicine infrastructure designed to meet the demands of modern healthcare delivery. The Aire02 system which was built on blueBriX’s platform comes with secure integration. By leveraging blueBriX’s robust telemedicine capabilities, Vivos could deliver effective remote therapy, ensuring patient engagement and adherence while maintaining the highest standards of data security and compliance.
Facilitates high-quality remote therapy sessions, ensuring continuity of care without geographical constraints.
Ensures all virtual interactions are securely recorded and stored, maintaining compliance with healthcare regulations.
Streamlines appointment scheduling and management, enhancing operational efficiency for providers.
Built-in secure video sessions with streamlined join, schedule, and management flows facilitate effective remote consultations. Supports expansion, accommodating a growing patient base while maintaining service quality.
The MyoSync App, built on the blueBriX platform, empowers patients by allowing them to self-schedule appointments, access guided therapy exercises, track their progress in real-time, and engage with personalized educational content. This user-friendly interface enhances patient involvement and adherence to therapy plans, resulting in improved satisfaction and health outcomes.
Tailors engagement strategies to individual patient needs, promoting active participation in care plans.
Enables patients to monitor their therapy progress, fostering motivation and accountability.
Provides access to condition-specific content, enhancing patient understanding and self-management.
Facilitates secure messaging between patients and providers, ensuring continuous support and guidance.
To advance Vivos’ digital-first strategy, blueBriX developed a secure, modular patient engagement app tailored for MyoSync. Built on a scalable architecture, it empowers both patients and clinicians through a suite of integrated, user-centric features:
Seamless SSO-enabled login via blueSSO simplifies the onboarding process, enhancing user experience.
The integrated HCP Dashboard synchronizes with patient activities, offering providers comprehensive insights into patient progress and adherence.
Clinicians can assign therapy packages, monitor progress, and dynamically update content, ensuring tailored care delivery.
Patients can self-schedule appointments, access guided therapy exercises, track real-time progress, and engage with personalized educational content, enhancing adherence and satisfaction.
The integration of Aire02 and the MyoSync App has led to improved patient satisfaction and therapy compliance, more efficient provider workflows, and a scalable solution poised to meet increasing demand across borders. Since launch, MyoSync has observed a steady increase in patient adoption. Within 3 months, more than 60 new users have actively engaged with the app, utilizing its features to schedule appointments, complete therapy exercises, and participate in tele-consultations. This milestone signifies a significant step in MyoSync's efficiency to delivering accessible, personalized care through mobile-first digital health solutions in partnership with blueBriX.
The Vivos–blueBriX partnership has transformed orofacial therapy delivery by digitizing care through the AireO2 system and the MyoSync App. With features like self-scheduling, real-time progress tracking, and secure communication, the patient engagement solution empowers patients and improves outcome. This digital-first approach lays the foundation for scalable, personalized, and outcome-driven value-based care.
